Protection from septic shock subsequent to injury by dsRNAs
US5763417A · kind A · utility
3Cited by
3References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/713
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of dsRNA for use in the reactivation of natural defense systems within human cells, tissues and organs reduced to inadequate function subsequent to injury. Specific treatments for various clinical phases of the biological continuous of an acquired immune deficient state are described. Protection from the toxic effects associated with increased TNF levels is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.